Inventor · disambiguated record
Julian Kim
Also filed as: KIM JULIAN · KIM JULIAN A
6 granted patents·2 pending applications·68 citations·filing 1994–2021
77Inventor score
Files withUNIV CASE WESTERN RESERVE4OHIO STATE UNIVERSITY RESEARCH FOUND1RIBOZYME PHARM INC1SIRNA THERAPEUTICS INC1UNIV OHIO STATE RES FOUND1
Top patents by PatentIndex Score
8 records- 0179US5814295ADetermination of lymph nodes enriched in tumor reactive cells their proliferation and their use in adoptive cellular therapyUNIV OHIO STATE RES FOUND·Filed 1994·Granted Sep 29, 1998·49 cites·48 claims
- 0267US2009170197A1Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)SIRNA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 0365US12156884B2Cancer treatment using β-(1-3)-(1-4)-glucanUNIV CASE WESTERN RESERVE·Filed 2021·Granted Dec 3, 2024·0 cites·19 claims
- 0455US10946038B2Cancer treatment using beta-(1-3)-(1-4)-glucanUNIV CASE WESTERN RESERVE·Filed 2018·Granted Mar 16, 2021·0 cites·18 claims
- 0551US6093381AModulation of the sensitivity of tumor cells to chemotherapeuticsOHIO STATE UNIVERSITY RESEARCH FOUND·Filed 1997·Granted Jul 25, 2000·19 cites·20 claims
- 0648US9944898B2Method of generating tumor-specific T cellsUNIV CASE WESTERN RESERVE·Filed 2014·Granted Apr 17, 2018·0 cites·9 claims
- 0748US2004102389A1Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)RIBOZYME PHARM INC·Filed 2002·Application pending·0 cites
- 0839US11071754B2Method of generating tumor-specific T cellsUNIV CASE WESTERN RESERVE·Filed 2018·Granted Jul 27, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Julian Kim files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →